Rituximab Therapy for Severe Cutaneous Leukocytoclastic Angiitis Refractory to Corticosteroids, Cellcept and Cyclophosphamide

Publisher： Karger

E-ISSN： 1662-6567|5|1|115-119

ISSN： 1662-6567

Source： Case Reports in Dermatology, Vol.5, Iss.1, 2013-04, pp. : 115-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cutaneous Leukocytoclastic Vasculitis in Dermatomyositis Suggests Malignancy

By  

Dermatology, Vol. 202, Iss. 2, 2001-04 ,pp. : 123-126

Karger

Access to resources Recommend Favorite

Cetuximab Therapy of Metastasizing Cutaneous Squamous Cell Carcinoma in a Patient with Severe Recessive Dystrophic Epidermolysis Bullosa

By  

Dermatology, Vol. 219, Iss. 1, 2009-05 ,pp. : 80-83

Karger

Access to resources Recommend Favorite

Complete Remission of Schnitzler Syndrome and Waldenström Macroglobulinemia under Rituximab-Cyclophosphamide-Dexamethasone

By  

Dermatology, Vol. 230, Iss. 1, 2014-11 ,pp. : 18-22

Karger

Access to resources Recommend Favorite

Treatment of Refractory Pemphigus with the Anti-CD20 Monoclonal Antibody (Rituximab)

By  

Dermatology, Vol. 214, Iss. 4, 2007-04 ,pp. : 310-318

Karger

Access to resources Recommend Favorite

Lipomatous Metaplasia after Severe and Chronic Cutaneous Inflammation

By  

Dermatology, Vol. 217, Iss. 1, 2008-04 ,pp. : 52-55

Karger

Access to resources Recommend Favorite